mHealth Patient Adoption: Gaps Watchdogs Must Fix
New peer-reviewed studies expose mHealth patient adoption barriers—from literacy gaps to wearable distrust—that regulators and providers have yet to address.
Independent · Biosignal Media
Straight reporting on telehealth access — GLP-1s, peptides, HRT, longevity and more. How to actually get treatment online, whether a provider is legit, what it costs, and what the law says.
Getting Treatment Online How online GLP-1 prescribing actually works A telehealth visit can end with a semaglutide prescription in minutes. Here's what a legitimate process looks like — and where the shortcuts should worry you. New peer-reviewed studies expose mHealth patient adoption barriers—from literacy gaps to wearable distrust—that regulators and providers have yet to address.
Mobile health coaching shows real results—but retention failures, equity gaps, and weak oversight put vulnerable groups at risk. What the data show.
New research exposes cardiac stress test accuracy failures between local sites and core labs. Here's what patients and watchdogs need to know.
Telehealth coverage gaps shift costs onto patients in Ghana, the U.S., and beyond. A watchdog review of seven studies shows who pays when systems fail.
Telehealth documentation failures across neurology, opioid care, and drug prescribing expose patients to serious risk. Here's what the research shows.
Home treatment safety gaps in chemotherapy, ICU monitoring, and at-home diagnostics demand urgent oversight. What new research reveals.
A step-by-step guide to obtaining semaglutide or tirzepatide through telehealth — eligibility, the process, what it costs, and how to avoid the traps.
Testosterone therapy is a few clicks away — but it's a controlled substance that needs bloodwork and a real evaluation. Here's the legitimate path and the red flags.